Table 1 inclusion and exclusion criteria

1.

Registered in CRAMP database with one of the following neuromuscular diseases

➢ Myotonic Dystrophy type 1. genetically proven (classic and juvenile type)

➢ McArdles disease, Glycogen Storage Disease Type V. Biochemically and genetically proven

➢ Facioscapulohumeral Muscular Dystrophy (FSHD). genetically determined

➢ Chronic progressive external ophthalmoplegia (CPEO) as defined by Emery

➢ Oculopharyngeal Muscular Dystrophy (OPMD). genetically determined

➢ Inclusion body myositis (IBM)as defined by Badrising and Verschuuren.

➢ Non-dystrophic myotonias. These skeletal muscle channelopathies include two main groups: the chloride and sodium channelopathies.

➢ Myositis: Dermatomyositis and Polymyositis

➢ Polyneuropathy: CMT1 & HNPP

2.

Age > 18 years

3.

Patients and their partners are control patients in care at the department of neurology RUNMC

Exclusion criteria

1.

Patients or partners with severe hearing problems

2.

Patients or partners who cannot speak, read or understand the Dutch language well

3.

Patients and their partner who have had a control visit with a neurologist at the neurology department of the RUNMC less than 6 months ago